APO RESEARCH · REPORT
Veterinary Vaccine Adjuvants
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Product & engineering
Understand the product.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Selected research
Industry Research
Veterinary Vaccine Adjuvants Industry Research Report 2026
Market perspective
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
Europe is the largest region of Veterinary Vaccine Adjuvants, with a market share about 35%. It was followed by North America with 30%. SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma and MVP Laboratories are the top 5 manufacturers of industry, and they had about 70% combined market share.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Vaccine Adjuvants market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Vaccine Adjuvants Market by Company
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Veterinary Vaccine Adjuvants Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Veterinary Vaccine Adjuvants Segment by Application
Livestock Vaccines
Companion Animals Vaccines
Veterinary Vaccine Adjuvants Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Vaccine Adjuvants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Subcutaneous
- Intramuscular
- Others
Applications
- Livestock Vaccines
- Companion Animals Vaccines
Companies covered
- SEPPIC
- SDA BIO
- Croda International Plc
- SPI Pharma
- MVP Laboratories
- Zhuoyue
- Zhiju Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Vaccine Adjuvants Market Size (2021-2032)
- 2.2.2 Global Veterinary Vaccine Adjuvants Sales (2021-2032)
- 2.2.3 Global Veterinary Vaccine Adjuvants Market Average Price (2021-2032)
- 2.3 Veterinary Vaccine Adjuvants by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Subcutaneous
- 2.3.4 Intramuscular
- 2.3.5 Others
- 2.4 Veterinary Vaccine Adjuvants by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Livestock Vaccines
- 2.4.3 Companion Animals Vaccines
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Vaccine Adjuvants Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Vaccine Adjuvants Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Vaccine Adjuvants Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Vaccine Adjuvants Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Vaccine Adjuvants, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Vaccine Adjuvants, Established Date
- 3.9 Global Veterinary Vaccine Adjuvants Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 SEPPIC
- 4.1.1 SEPPIC Company Information
- 4.1.2 SEPPIC Business Overview
- 4.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Portfolio
- 4.1.5 SEPPIC Recent Developments
- 4.2 SDA BIO
- 4.2.1 SDA BIO Company Information
- 4.2.2 SDA BIO Business Overview
- 4.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Portfolio
- 4.2.5 SDA BIO Recent Developments
- 4.3 Croda International Plc
- 4.3.1 Croda International Plc Company Information
- 4.3.2 Croda International Plc Business Overview
- 4.3.3 Croda International Plc Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Croda International Plc Veterinary Vaccine Adjuvants Product Portfolio
- 4.3.5 Croda International Plc Recent Developments
- 4.4 SPI Pharma
- 4.4.1 SPI Pharma Company Information
- 4.4.2 SPI Pharma Business Overview
- 4.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio
- 4.4.5 SPI Pharma Recent Developments
- 4.5 MVP Laboratories
- 4.5.1 MVP Laboratories Company Information
- 4.5.2 MVP Laboratories Business Overview
- 4.5.3 MVP Laboratories Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MVP Laboratories Veterinary Vaccine Adjuvants Product Portfolio
- 4.5.5 MVP Laboratories Recent Developments
- 4.6 Zhuoyue
- 4.6.1 Zhuoyue Company Information
- 4.6.2 Zhuoyue Business Overview
- 4.6.3 Zhuoyue Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zhuoyue Veterinary Vaccine Adjuvants Product Portfolio
- 4.6.5 Zhuoyue Recent Developments
- 4.7 Zhiju Bio
- 4.7.1 Zhiju Bio Company Information
- 4.7.2 Zhiju Bio Business Overview
- 4.7.3 Zhiju Bio Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zhiju Bio Veterinary Vaccine Adjuvants Product Portfolio
- 4.7.5 Zhiju Bio Recent Developments
5 Global Veterinary Vaccine Adjuvants Market Scenario by Region
- 5.1 Global Veterinary Vaccine Adjuvants Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2027-2032
- 5.3 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Vaccine Adjuvants Revenue by Region: 2027-2032
- 5.4 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
- 5.4.1 North America Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Vaccine Adjuvants Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Vaccine Adjuvants Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Vaccine Adjuvants Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Vaccine Adjuvants Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
- 5.7.1 South America Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Vaccine Adjuvants Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Vaccine Adjuvants Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021-2032) & (t)
- 6.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Vaccine Adjuvants Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021-2032) & (t)
- 7.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Vaccine Adjuvants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Vaccine Adjuvants Value Chain Analysis
- 8.1.1 Veterinary Vaccine Adjuvants Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Vaccine Adjuvants Production Mode & Process
- 8.2 Veterinary Vaccine Adjuvants Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Vaccine Adjuvants Distributors
- 8.2.3 Veterinary Vaccine Adjuvants Customers
9 Global Veterinary Vaccine Adjuvants Analyzing Market Dynamics
- 9.1 Veterinary Vaccine Adjuvants Industry Trends
- 9.2 Veterinary Vaccine Adjuvants Industry Drivers
- 9.3 Veterinary Vaccine Adjuvants Industry Opportunities and Challenges
- 9.4 Veterinary Vaccine Adjuvants Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst